Patient and Physician Behavior
Featured Topics
Lead story
Other featured articles
-
Extended-Release Formulation and Medication Adherence
Suboptimal adherence to chronic medications undermines treatment effectiveness and costs the U.S. as much as $289 billion annually. This is the first study to analyze the impact of extended-release formulations on long-term adherence.
Posted in -
A Decade of Research with Impact
From redefining value in cancer treatments to predicting the impact of changes in demographics to enhancing Medicare, the Schaeffer Center does more than inform policy — it helps drive decisions to improve delivery of care, foster innovation and enhance healthcare markets.
Posted in -
Informing Clinicians of a Patient’s Fatal Overdose Changes Their Prescribing Behavior
When a clinician is given information about a patient’s fatal overdose caused by prescription opioids, they decrease their opioid prescribing.
Posted in -
Are High-Deductible Plans a Healthy Option for Patients?
High-deductible health plans may have unintended consequences for patients.
Posted in
About this section
Patients as well as providers must take responsibility in improving healthcare, but human fallibility can impede success. The Schaeffer Center fosters supportive and effective ways to improve the decision-making of all parties for healthier results.
Our Experts On Patient and Physician Behavior
Our Work In Patient and Physician Behavior
-
BMJ: What Current and Missing Data Can Teach Us About Medication Errors
The cost of medication errors worldwide exceeds $42 billion, or approximately 5%–6% of all hospitalizations. There are a number of cost-effective strategies that could be deployed to reduce the quantity of adverse drug events.
Categorized in -
The Need To More Effectively Regulate END Markets: A Primary Public Health Lesson of the US Vaping Associated Lung Injury Outbreak
The designation of END products as “tobacco products” rather than “medical products” in August 2016 meant manufacturers did not have to meet pharmaceutical safety standards; instead, minimal product safety regulations were imposed.
Categorized in -
New Digital Health Project Will Include Traditionally Underrepresented Americans
Ritika Chaturvedi will lead the American Life in Real-time (ALiR) project, which will use digital technologies to create precision public health interventions that focus on reducing health disparities.
-
Uptake of Infliximab Biosimilars Among the Medicare Population
Two years after launch, biosimilars for rheumatoid arthritis and other lifelong conditions captured little market share.
Categorized in -
State Approaches to Tackling the Opioid Crisis Through the Health Care System
States have implemented multiple strategies to enhance the capacity and quality of treatment services for opioid use disorder.
-
Pacula Examines Pitfalls in the Legalized Marijuana Marketplace
As the marijuana industry marches toward mainstream acceptance, policymakers are turning to Rosalie Liccardo Pacula to help ensure that its popularity does not outpace scientific understanding of its risks.